Fluoxetine epigenetically alters the CaMKIIα promoter in nucleus accumbens to regulate ΔFosB binding and antidepressant effects.
about
β-catenin mediates stress resilience through Dicer1/microRNA regulationDifferential Expression of FosB Proteins and Potential Target Genes in Select Brain Regions of Addiction and Depression PatientsReward Network Immediate Early Gene Expression in Mood DisordersThreonine 149 phosphorylation enhances ΔFosB transcriptional activity to control psychomotor responses to cocaine.Epigenetic signaling in psychiatric disorders.Epigenetic signaling in psychiatric disorders: stress and depression.∆FosB: a transcriptional regulator of stress and antidepressant responses.HCN Channel Targets for Novel Antidepressant Treatment.Peripheral and Central Mechanisms of Stress Resilience.Fluoxetine exposure during adolescence increases preference for cocaine in adulthoodDifferential induction of FosB isoforms throughout the brain by fluoxetine and chronic stressNeuronal correlates of depression.Neurogenetics and gene therapy for reward deficiency syndrome: are we going to the Promised Land?Epigenetic Basis of Mental Illness.Improving treatment of neurodevelopmental disorders: recommendations based on preclinical studies.Histone Modifications in Major Depressive Disorder and Related Rodent Models.Reduced Slc6a15 in Nucleus Accumbens D2-Neurons Underlies Stress Susceptibility.Treating the Synapse in Major Psychiatric Disorders: The Role of Postsynaptic Density Network in Dopamine-Glutamate Interplay and Psychopharmacologic Drugs Molecular ActionsRole of hippocampal activity-induced transcription in memory consolidation.Emerging Role for Nucleus Accumbens Medium Spiny Neuron Subtypes in Depression.Cell-Type-Specific Epigenetic Editing at the Fosb Gene Controls Susceptibility to Social Defeat Stress.GluN1 deletions in D1- and A2A-expressing cell types reveal distinct modes of behavioral regulation.Forebrain glutamatergic, but not GABAergic, neurons mediate anxiogenic effects of the glucocorticoid receptor.Disrupted hippocampal neuregulin-1/ErbB3 signaling and dentate gyrus granule cell alterations in suicide.Enhancing VTA Cav1.3 L-type Ca2+ channel activity promotes cocaine and mood-related behaviors via overlapping AMPA receptor mechanisms in the nucleus accumbens.Beneficial effect of fluoxetine treatment aganist psychological stress is mediated by increasing BDNF expression in selected brain areas.Chronic antidepressant potentiates spontaneous activity of dorsal raphe serotonergic neurons by decreasing GABAB receptor-mediated inhibition of L-type calcium channels.Long non-coding RNA-associated transcriptomic changes in resiliency or susceptibility to depression and response to antidepressant treatment.A role for activity-dependent epigenetics in the development and treatment of major depressive disorder.Chronic Fluoxetine Induces Activity Changes in Recovery From Poststroke Anxiety, Depression, and Cognitive Impairment.Cell-Type-Specific Role of ΔFosB in Nucleus Accumbens In Modulating Intermale AggressionΔFosB Decreases Excitability of Dorsal Hippocampal CA1 Neurons
P2860
Q28251285-BAF8BC6F-A564-444F-9547-90FF17039332Q28553391-0505CA81-3C77-404E-BE6E-9D4AD4E33ED7Q33611438-25BE059F-FEDE-495D-8717-C91A017C4A85Q34067381-88472F1F-C506-4D36-9CE2-A7B49A9C676DQ34254501-25225237-468B-4CD9-88BF-39014212E5E8Q34426179-8869E40C-A4B4-4B15-A016-A8A6AC7AD553Q34450682-9C2C3F05-788D-4F74-AD5E-8F9CF452302DQ34557298-109196CD-5CDB-4769-A0DC-3DCDEE1839A4Q34660056-17810072-45A9-47E7-A4E5-B2ED3C44458DQ36139355-C6A83506-B994-4F16-BBAF-672064946D9FQ36304798-30D54081-B6C2-47D1-A75A-D05FB77C3F4AQ36451816-717FB49E-43C3-4842-9F81-DBE0C4495F5BQ38479762-51ADBCE0-3899-4B2E-AC16-3363DB0342DCQ38602855-4F9CC1A3-1C3B-4DD6-839C-78A75D6AB7E0Q38630671-86FEBC1C-7633-44CC-B088-AE0FDFD032A6Q38681922-DAC6D256-E89D-44B1-842B-0E0D8828FE37Q38747486-D44B42B8-7A29-4C9F-B90E-02648F4724B1Q38770806-26DB6209-E273-4EA4-8CD5-FC2CCA70C633Q38867124-167E2E60-972E-46BF-9F84-A96C3B8F6A94Q39015823-AFC5D259-3FE9-46F1-B2B7-82F0F0D8CDF4Q39306654-7E258A38-6222-49CB-A4E5-CA300792EAC4Q39890360-35993E07-9D3D-4313-9560-39C303E0397AQ40728572-A36450EA-7B45-47FF-813D-E38A30FA0A23Q41196992-5B4D24F6-C035-4222-9BE4-BA4A8AD09FB1Q41385264-48A2E004-294C-4AAA-BEDF-1FB0A23053BFQ42378356-4C3797ED-5D78-4D31-9745-FDC2A4A09D31Q42670375-F6920827-C8C0-4FC0-B10F-986620CEE4DFQ47639671-E1250091-338B-4C91-986C-C5E28D9E38B2Q47676118-E4AD8727-C6DC-4461-B78F-29457B1F3969Q47687614-C552D780-C56B-4F1B-9AFC-3F2F3E4CA2ECQ57086352-EFD39674-A950-4C28-9144-3AB94DD0C162Q58802547-809F9121-7688-484D-8A48-77A389AD5CDD
P2860
Fluoxetine epigenetically alters the CaMKIIα promoter in nucleus accumbens to regulate ΔFosB binding and antidepressant effects.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Fluoxetine epigenetically alte ...... ng and antidepressant effects.
@en
Fluoxetine epigenetically alte ...... ng and antidepressant effects.
@nl
type
label
Fluoxetine epigenetically alte ...... ng and antidepressant effects.
@en
Fluoxetine epigenetically alte ...... ng and antidepressant effects.
@nl
prefLabel
Fluoxetine epigenetically alte ...... ng and antidepressant effects.
@en
Fluoxetine epigenetically alte ...... ng and antidepressant effects.
@nl
P2093
P2860
P50
P356
P1476
Fluoxetine epigenetically alte ...... ng and antidepressant effects.
@en
P2093
A J Robison
Benoit Labonte
Carol Tamminga
Caroline Dias
Hao-Sheng Sun
P2860
P2888
P304
P356
10.1038/NPP.2013.319
P407
P577
2013-11-15T00:00:00Z